EU start-up funding is creating massive economic impact

Europe has turned 12 billion euros of start-up funding into a half-trillion-euros tech jackpot.

When the European Union pours money into start-ups, it doesn’t just fund ideas—it unlocks immense value. A new report by Dealroom, Dealflow.eu, and EU-Startups reveals that 12 billion euros in direct EU grants from framework programmes such as Horizon have catalysed a staggering 520 billion euros in total company value.

That 12 billion euros sparked another 70 billion euros from private venture capitalists, nurturing an ecosystem now responsible for a tenth of Europe’s entire venture-backed startup market.

The Dealroom analysis, covering 13,600 start-ups funded by EU programmes, is the first comprehensive look at how Brussels’ backing has shaped innovation on the continent.

Over four decades, the EU has channelled significant funds through its major innovation drives: the Seventh Framework Programme, Horizon 2020, and Horizon Europe.

Start-ups received a mere five per cent (12 billion euros) of the 225 billion euros total—but the returns have been spectacular.

De-risking innovation

Notable beneficiaries include BioNTech, maker of a game-changing Covid vaccine, and ARM, the British mobile-chip giant boosted by earlier EU grants. ARM alone is a global success story, though its valuation isn’t included in the report’s primary 400 billion euros tally—add it, and total EU-supported value creation reaches that eye-popping 520 billion euros.

EU funding, crucially, skews heavily towards frontier technology: nearly three-quarters of funded start-ups manufacture physical products, compared to just a quarter in Europe’s broader start-up ecosystem.

Key sectors enjoying outsized benefits include space tech, semiconductors, climate tech, and robotics. Importantly, these EU-backed ventures are more successful at securing follow-up venture rounds, underscoring Brussels’ role in de-risking and launching future tech champions.

Yoram Wijngaarde, founder and CEO of Dealroom, calls the data “exciting and important”.

He notes, “Public funding can de-risk early innovation and pave the way for private capital with remarkable outcomes. Beyond pure financial returns, successes like BioNTech and ARM represent major strategic wins in critical technology domains.”

Time for more funding

Given start-ups’ impressive returns from minimal EU allocations, Wijngaarde argues strongly for increased future investment.

“Given that start-ups represent just five per cent of framework programme funding but deliver such transparent, traceable and promising returns, there’s a strong case for increasing their allocation in future programmes,” he says.

Complexity and fragmentation of funding programmes also pose persistent hurdles for young companies seeking support.

The report advises the European Commission to ramp up start-up investment in Horizon Europe’s successor programme, streamline its myriad funding channels into a single, coherent pathway for grants, equity, and mentorship, and boost start-ups’ visibility through enhanced summits and pitch events.

Digital platforms such as Dealflow.eu and Innovation Radar should also be leveraged further, offering real-time startup insights to better connect investors and entrepreneurs.

For Europe, the lesson is clear: modest investment in young innovators doesn’t just deliver financial returns—it builds strategic advantage, too. Brussels would do well to double down.

Photo by Clark Tibbs on Unsplash.

At Emerging Europe, we use an integrated approach centred around market intelligence to help organisations understand trends and strategically position themselves for success.  

Learn how our solutions can help you thrive in the region:

Company and Services Overview | Strategic Advantage.